ShermanSI, LadensonPW. 1992. Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects. J Clin Endocrinol Metab, 75:901–905.
2.
GoldmanS, McCarrenM, MorkinE, LadensonPW, EdsonR, WarrenS, OhmJ, ThaiH, ChurbyL, BarnhillJ, O'BrienT, AnandI, WarnerA, DunlapM, HattlerB, EriksonJ, ShihM-C, LavoriP. 2009. DITPA, a thyroid hormone analogue to treat heart failure: Phase II Trial VA Cooperative Study. Circulation, 119:3093–3100.
3.
ShermanSI, GopalJ, HaugenBR, ChiuAC, WhaleyK, NowlakhaP, DuvicM. 1999. Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med, 340:1075–1079.
4.
ScanlanTS. 2010. Sobetirome: a case history of bench-to-clinic drug discovery and development. Heart Fail Rev, 15:177–182.
5.
BerkenstamA, KristensenJ, MellströmK, CarlssonB, MalmJ, RehnmarkS, GargN, AnderssonCM, RudlingM, SjöbergF, AngelinB, BaxterJD. 2008. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci U S A, 105:663–667.
6.
ErionMD, CableEE, ItoBR, JiangH, FujitakiJM, FinnPD, ZhangBH, HouJ, BoyerSH, van PoeljePD, LinemeyerDL. 2007. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci U S A, 104:15490–15495.
7.
LadensonPW, KristensenJD, RidgwayEC, OlssonAG, CarlssonB, KleinI, BaxterJD, AngelinB. 2010. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med, 362:906–916.
8.
O'GormanCS, HigginsMF, O'NeillMB. 2009. Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatr Cardiol, 30:482–489.
9.
DavisPJ, LeonardJL, DavisFB. 2008. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol, 29:211–218.
MalmJ, FärnegårdhlM, GroverGJ, KoehlerK, LadensonPW. 2009. Thyroid hormone antagonists: potential medical applications and structure activity relationships. Curr Med Chem, 16:3258–3266.
12.
Di CosmoC, LiaoXH, DumitrescuAM, WeissRE, RefetoffS. 2009. A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport. Endocrinology, 150:4450–4458.
13.
GuranT, TuranS, BircanR, BereketA. 2009. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC)J Pediatr Endocrinol Metab, 22:971–978.
